Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

We recently published 10 Stocks on Jim Cramer’s Radar. Johnson & Johnson (NYSE:JNJ) is one of the stocks that on Jim Cramer’s radar. Pharma giant Johnson & Johnson (NYSE:JNJ)’s shares are up by 53% ...

Dividend stocks can be appealing for investors who want a steady income stream. Here are the best quality dividend stocks to ...

Compass Pathways is rated a Hold due to high risk, funding needs, and the need for further data before reassessing the thesis ...

Johnson & Johnson, Meta Platforms Inc, Taiwan Semiconductor Manufacturing. Read 's Market Analysis on Investing.com India ...

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real ...

Cooper Companies faces moderating revenue growth and margin leverage despite strong execution and market share gains. Find ...

Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. Stocks moved higher on Wednesday, driven by ...

Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical, Insmed and Madrigal ...

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J’s ...

Pentair plc (PNR) delivered its latest quarterly dividend of $0.27 per share on February 6, 2026, marking another milestone in a streak that now spans 50 consecutive years of annual dividend increases ...

Blue-chip dividend stocks delivered mixed returns last week as investors weighed earnings reports, dividend announcements, and shifting interest rate expectations. With 10-year Treasury yields ...